Drug Shortage Report for TEVA-ESOMEPRAZOLE
Report ID | 115207 |
Drug Identification Number | 02423855 |
Brand name | TEVA-ESOMEPRAZOLE |
Common or Proper name | ESOMEPRAZOLE 20MG OG TABLET |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 30UD |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-05-13 |
Estimated end date | 2021-07-31 |
Actual end date | 2021-07-21 |
Shortage status | Resolved |
Updated date | 2021-07-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v20 | 2021-07-22 | French | Compare |
v19 | 2021-07-22 | English | Compare |
v18 | 2021-06-24 | French | Compare |
v17 | 2021-06-24 | English | Compare |
v16 | 2021-05-20 | French | Compare |
v15 | 2021-05-20 | English | Compare |
v14 | 2021-05-10 | French | Compare |
v13 | 2021-05-10 | English | Compare |
v12 | 2021-05-06 | French | Compare |
v11 | 2021-05-06 | English | Compare |
v10 | 2021-04-01 | French | Compare |
v9 | 2021-04-01 | English | Compare |
v8 | 2021-02-11 | French | Compare |
v7 | 2021-02-11 | English | Compare |
v6 | 2021-01-07 | French | Compare |
v5 | 2021-01-07 | English | Compare |
v4 | 2020-08-06 | French | Compare |
v3 | 2020-08-06 | English | Compare |
v2 | 2020-05-14 | French | Compare |
v1 | 2020-05-14 | English | Compare |
Showing 1 to 20 of 20